Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, H.
Right arrow Articles by Wu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, H.
Right arrow Articles by Wu, X.
[Cancer Research 61, 7819-7824, November 1, 2001]
© 2001 American Association for Cancer Research


Epidemiology and Prevention

{gamma}-Radiation-induced G2 Delay, Apoptosis, and p53 Response as Potential Susceptibility Markers For Lung Cancer

Hua Zhao1, Margaret R. Spitz, Gail E. Tomlinson, Huifeng Zhang, John D. Minna and Xifeng Wu2

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [H. Zhao, M. R. S., H. Zhan., X. W.]; The University of Texas—School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas 77030 [H. Zhao]; and The University of Texas Southwestern Medical Center, Hamon Cancer for Therapeutic Oncology Research, Dallas, Texas 75390 [G. E. T., J. D. M.]

{gamma}-Radiation results in cell cycle arrest and apoptosis in a wide variety of cells. Cell cycle arrest provides time for the cell to repair damaged DNA before entering the next phase of the cycle. If the damage is severe and cannot be repaired, the cells undergo apoptosis. However, if the damaged cells continue to grow without repair or apoptosis, then carcinogenic transformation may occur. We hypothesized that individuals with inherited disruption in cell cycle control and/or apoptosis and/or DNA repair may be susceptible to lung cancer development. The cells from susceptible individuals would have a shorter G2 period and less apoptosis compared with cells from normal individuals upon exposure to {gamma}-radiation. To test this hypothesis, the following methods were used: (a) fluorescence-activated cell sorting method was used to measure apoptosis and G2 cell cycle delay; (b) the ELISA method was used to measure p53 protein expression levels in these cell lines; and (c) {gamma}-radiation-induced chromatid breaks were counted as a marker for DNA damage or repair. Next, {gamma}-radiation-induced G2 delay and apoptosis were tested in three lymphoblastoid cell lines to determine the dose response effect and optimal time points of {gamma}-radiation. Finally, these assays were tested in lymphoblastoid cell lines from 30 lung cancer patients and 22 healthy controls. We found a dose-response relationship for {gamma}-radiation-induced G2 delay and apoptosis. The optimal time points to detect differential G2 delay and apoptotic index were 10 h and 48 h after {gamma}-radiation, respectively. The mean G2 delay was 22.5% ± 10.5% for the control cell lines and 14.71% ± 8.8% for case cell lines (P < 0.01). The mean apoptotic index was 20.4% ± 11.7% for the controls and 14.3% ± 7.8% for the cases (P < 0.05). The controls had a significantly higher p53 response ratio and fewer chromatid breaks than the cases. We also found that a p53 increasing ratio was strongly related to cell cycle G2 delay ({gamma} = 0.413; P = 0.002) and chromatid breaks ({gamma} =0.384; P = 0.028). Therefore, we concluded that {gamma}-radiation-induced G2 delay, apoptosis, p53 increasing ratio, and chromatid breaks might potentially be used as susceptibility markers for lung cancer risk. A large epidemiology study is in progress to confirm these findings.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Xing, M. R. Spitz, C. Lu, H. Zhao, H. Yang, W. Wang, D. J. Stewart, and X. Wu
Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1517 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Xing, Y. Zhu, H. Zhao, H. Yang, M. Chen, M. R. Spitz, and X. Wu
Differential Induction in Telomerase Activity among Bladder Cancer Patients and Controls on {gamma}-Radiation
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 606 - 609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wu, J. A. Roth, H. Zhao, S. Luo, Y.-L. Zheng, S. Chiang, and M. R. Spitz
Cell Cycle Checkpoints, DNA Damage/Repair, and Lung Cancer Risk
Cancer Res., January 1, 2005; 65(1): 349 - 357.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
X. Wu, H. Zhao, C. I. Amos, S. Shete, N. Makan, W. K. Hong, F. F. Kadlubar, and M. R. Spitz
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity
J Natl Cancer Inst, May 1, 2002; 94(9): 681 - 690.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.